Healthcare

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 22 Aug 2013  |  North America  |  Technology Research

    Advances in Tissue Engineering and Organ Regeneration (Technical Insights)

    State-of-the-Art Technology for Artificial Organ Implant

    Tissue engineering, which is now being categorized as a form of regenerative medicine, can be defined as biomedical engineering to reconstruct, repair, and improve biological tissues. Research efforts in tissue engineering have been ongoing and it is emerging as one of the key areas of medical research. Furthermore, there are vast developments in t...

    $4,950.00
  2. 31 Mar 2015  |  North America  |  Technology Research

    Technology Trends in Women's Health (Technical Insights)

    Toward better and affordable healthcare for women

    In almost all parts of the world, women live longer than men. The exact cause behind the differential between male and female life expectancy is uncertain, but it appears to be partly explained by biological advantages and partly by environmental and behavioral factors. However, as women outlive men, they are more prone to suffering from ill healt...

    $3,950.00
  3. 29 Jun 2015  |  North America  |  Technology Research

    Breakthroughs in Small Animal Imaging_Technical Insights

    The Future to Disease Detection and Prevention

    The small animal imaging or in vivo preclinical imaging market began to come into existence from the early 1990s when scientists studying biology and disease processes realized that clinical image could help them reduce the cost of research and time span of their animal studies. At present, medical imaging is an important tool in research applicati...

    $4,950.00
  4. 30 Dec 2015  |  North America  |  Technology Research

    Innovations in wound care and healing (TechVision)

    Progress toward the ultimate goal of achieving true regeneration

    The wound healing industry has undergone both radical and incremental innovations to suit the demands of the growing patient pool. The research report shows how technology convergence is instrumental to the development of advanced wound care products. This research service covers the innovations in this industry, its drivers and challenges and also...

    $4,950.00
  5. 30 Mar 2016  |  North America  |  Technology Research

    Enabling Technologies in Global Surgical Robots Market

    Robot-assisted Surgeries to Revolutionize Orthopedic, Gastrointestinal, Obstetrics/ Gynecological, Neurosurgery and Ocular Applications

    Robots have increasingly become important in the field of surgical interventions due to growing complexity of surgical procedures for difficult diseases, and greater demand towards minimal invasive surgery. This research service highlights technological advances and innovations in surgical robots. The R&D network driving the growth of surgical robo...

    $4,950.00
  6. 29 Dec 2017  |  North America  |  Technology Research

    Innovations in Transdermal Drug Delivery

    Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry

    With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...

    $4,950.00
  7. 02 May 2018  |  North America  |  Technology Research

    Breakthrough Innovations in PoC Diagnostics for Smart Healthcare

    Rapid, Accessible, and Affordable Diagnostics Augmenting Healthcare

    Today, the healthcare industry is focused toward patient centric care and preventative healthcare. Preventative healthcare involves regular screening and diagnosis for diseases before the condition becomes fatal. Early diagnosis improves the clinical outcome of the patients, reduces emergency visits, and subsequently healthcare costs. Usually, ear...

    $4,950.00
  8. 28 Sep 2018  |  North America  |  Technology Research

    Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments

    A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present

    The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

    $4,950.00
  9. 30 Mar 2019  |  North America  |  Technology Research

    Game-changing Innovations Transforming Cardiovascular Care

    Minimally Invasive Surgical Interventions & Digital Advances Driving the Future of Cardiac Care

    TechVision's latest research service from the medical device technology cluster highlights the game changing innovations in cardiovascular care. Although cardiovascular devices have been in use for decades, over the last few years, there have been some major developments in cardiovascular care. The technology innoavtions are powered by rapid advanc...

    $4,950.00
  10. 30 Mar 2019  |  North America  |  Technology Research

    Breakthroughs in Non-Alcoholic Steatohepatitis Management

    Multiple Investigational New Drugs with high potential for better treatment outcomes progressing through critical stages of clinical development

    Non-Alcoholic Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition. Multiple drugs are at ...

    $4,950.00